Proton pump inhibitor use associated with changes in gut microbiota composition.
作者信息
Reveles Kelly R, Ryan Caitlin N, Chan Luisa, Cosimi Reese A, Haynes Wanda L
机构信息
College of Pharmacy, The University of Texas at Austin, San Antonio, Texas, USA.
Pharmacotherapy Education and Research Center, UT Health San Antonio, San Antonio, Texas, USA.
出版信息
Gut. 2018 Jul;67(7):1369-1370. doi: 10.1136/gutjnl-2017-315306. Epub 2017 Oct 9.
Abstract
摘要
相似文献
1
Proton pump inhibitor use associated with changes in gut microbiota composition.质子泵抑制剂的使用与肠道微生物群组成的变化有关。
Gut. 2018 Jul;67(7):1369-1370. doi: 10.1136/gutjnl-2017-315306. Epub 2017 Oct 9.
2
Editorial: further evidence that proton pump inhibitors may impact on the gut microbiota.社论：质子泵抑制剂可能影响肠道微生物群的进一步证据。
Aliment Pharmacol Ther. 2016 May;43(10):1104-5. doi: 10.1111/apt.13596.
3
Does Long-Term Proton Pump Inhibitor Therapy Affect the Health of Gut Microbiota?长期质子泵抑制剂治疗会影响肠道微生物群的健康吗？
Gut Liver. 2016 Nov 15;10(6):865-866. doi: 10.5009/gnl16438.
4
Proton pump inhibitors alter the composition of the gut microbiota.质子泵抑制剂会改变肠道微生物群的组成。
Gut. 2016 May;65(5):749-56. doi: 10.1136/gutjnl-2015-310861. Epub 2015 Dec 30.
5
Oral microbiome alterations of healthy volunteers with proton pump inhibitor.质子泵抑制剂对健康志愿者口腔微生物组的影响。
J Gastroenterol Hepatol. 2018 May;33(5):1059-1066. doi: 10.1111/jgh.14040. Epub 2018 Feb 14.
6
The role of gut microbiota in Clostridium difficile infection.肠道微生物群在艰难梭菌感染中的作用。
Eur J Intern Med. 2018 Apr;50:28-32. doi: 10.1016/j.ejim.2018.02.006. Epub 2018 Feb 7.
7
Proton pump inhibitor use status does not modify the microbiome signature for cirrhosis.质子泵抑制剂的使用状况不会改变肝硬化的微生物组特征。
Cell Metab. 2021 Mar 2;33(3):457. doi: 10.1016/j.cmet.2021.02.013.
8
Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.质子泵抑制剂使用导致的肠道菌群失调。
Digestion. 2018;97(2):195-204. doi: 10.1159/000481813. Epub 2018 Jan 6.
9
Comment on 'Proton Pump Inhibitors. Risks and Rewards and Emerging Consequences to the Gut Microbiome'.
Nutr Clin Pract. 2019 Feb;34(1):172. doi: 10.1002/ncp.10218. Epub 2018 Nov 21.
10
Response to Comment on 'Proton Pump Inhibitors. Risks and Rewards and Emerging Consequences to the Gut Microbiome'.
Nutr Clin Pract. 2019 Feb;34(1):173. doi: 10.1002/ncp.10217. Epub 2018 Nov 21.
引用本文的文献
1
Impact of concomitant medications on the oncologic efficacy of systemic therapy in patients with advanced or metastatic urothelial carcinoma: a systematic review and meta-analysis.合并用药对晚期或转移性尿路上皮癌患者全身治疗肿瘤疗效的影响：一项系统评价和荟萃分析。
BMC Urol. 2025 Apr 28;25(1):107. doi: 10.1186/s12894-025-01754-2.
2
Effects of proton pump inhibitor (PPI) use on migraine - a critical review.质子泵抑制剂（PPI）的使用对偏头痛的影响——一项批判性综述。
J Headache Pain. 2025 Jan 30;26(1):20. doi: 10.1186/s10194-025-01954-z.
3
Stability of Gastric Fluid and Fecal Microbial Populations in Healthy Horses under Pasture and Stable Conditions.放牧和厩养条件下健康马匹胃液及粪便微生物群落的稳定性
Animals (Basel). 2024 Oct 16;14(20):2979. doi: 10.3390/ani14202979.
4
Proton Pump Inhibitors and Oral-Gut Microbiota: From Mechanism to Clinical Significance.质子泵抑制剂与口腔-肠道微生物群：从作用机制到临床意义
Biomedicines. 2024 Oct 7;12(10):2271. doi: 10.3390/biomedicines12102271.
5
Changes in the Gastrointestinal Microbiota Induced by Proton Pump Inhibitors-A Review of Findings from Experimental Trials.质子泵抑制剂诱导的胃肠道微生物群变化——实验性试验结果综述
Microorganisms. 2024 May 30;12(6):1110. doi: 10.3390/microorganisms12061110.
6
Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome.益生元原花青素通过重塑肠道微生物组和食管代谢组抑制胆汁反流诱导的食管腺癌。
JCI Insight. 2024 Feb 8;9(6):e168112. doi: 10.1172/jci.insight.168112.
7
Association between concomitant proton pump inhibitor use and survival of patients with metastatic prostate cancer receiving abiraterone acetate: a post-hoc analysis of pooled data from three randomized controlled trials.接受醋酸阿比特龙治疗的转移性前列腺癌患者同时使用质子泵抑制剂与生存率之间的关联：来自三项随机对照试验的汇总数据的事后分析
Prostate Cancer Prostatic Dis. 2024 Sep;27(3):444-450. doi: 10.1038/s41391-023-00695-x. Epub 2023 Jul 18.
8
Evidence for proton-pump inhibitor (PPI)-associated dysbiosis in metabolically unhealthy obesity.质子泵抑制剂（PPI）相关的代谢不健康肥胖中的菌群失调的证据。
Front Endocrinol (Lausanne). 2023 Jun 15;14:1205490. doi: 10.3389/fendo.2023.1205490. eCollection 2023.
9
Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease.质子泵抑制剂使用对炎症性肠病患者临床结局的影响。
Ann Med. 2023 Dec;55(1):2198775. doi: 10.1080/07853890.2023.2198775.
10
Controversies in the Prevention and Treatment of Infection in Adults: A Narrative Review.成人感染预防与治疗中的争议：一篇叙述性综述
Microorganisms. 2023 Feb 3;11(2):387. doi: 10.3390/microorganisms11020387.
本文引用的文献
1
Effect of Bifidobacterium upon Clostridium difficile Growth and Toxicity When Co-cultured in Different Prebiotic Substrates.在不同益生元底物中共培养时双歧杆菌对艰难梭菌生长及毒性的影响
Front Microbiol. 2016 May 18;7:738. doi: 10.3389/fmicb.2016.00738. eCollection 2016.
2
Proton pump inhibitors alter the composition of the gut microbiota.质子泵抑制剂会改变肠道微生物群的组成。
Gut. 2016 May;65(5):749-56. doi: 10.1136/gutjnl-2015-310861. Epub 2015 Dec 30.
3
Proton pump inhibitors affect the gut microbiome.质子泵抑制剂会影响肠道微生物群。
Gut. 2016 May;65(5):740-8. doi: 10.1136/gutjnl-2015-310376. Epub 2015 Dec 9.
4
Identification of key taxa that favor intestinal colonization of Clostridium difficile in an adult Chinese population.在中国成年人群中鉴定有利于艰难梭菌肠道定植的关键分类群。
Microbes Infect. 2016 Jan;18(1):30-8. doi: 10.1016/j.micinf.2015.09.008. Epub 2015 Sep 14.
5
Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.抑酸药物和抗生素与艰难梭菌感染风险：荟萃分析。
Am J Gastroenterol. 2012 Jul;107(7):1011-9. doi: 10.1038/ajg.2012.108. Epub 2012 Apr 24.
6
Effects of proton pump inhibitors on gastric emptying: a systematic review.质子泵抑制剂对胃排空的影响：系统评价。
Dig Dis Sci. 2010 Sep;55(9):2431-40. doi: 10.1007/s10620-009-1076-x. Epub 2009 Dec 10.
7
Clinical trial: long-term use of proton pump inhibitors in primary care patients - a cross sectional analysis of 901 patients.临床试验：初级保健患者质子泵抑制剂的长期使用 - 对 901 名患者的横断面分析。
Aliment Pharmacol Ther. 2009 Oct;30(7):725-32. doi: 10.1111/j.1365-2036.2009.04092.x. Epub 2009 Jul 8.
8
Effect of pH and antibiotics on microbial overgrowth in the stomachs and duodena of patients undergoing percutaneous endoscopic gastrostomy feeding.pH值和抗生素对接受经皮内镜下胃造口术喂养患者胃和十二指肠微生物过度生长的影响。
J Clin Microbiol. 2005 Jul;43(7):3059-65. doi: 10.1128/JCM.43.7.3059-3065.2005.
9
Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection.人类粪便中主要细菌群落随年龄及艰难梭菌感染的变化
J Med Microbiol. 2002 May;51(5):448-454. doi: 10.1099/0022-1317-51-5-448.
Zotero 插件